Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

AVLN Free Cash Flow

Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.

No reported Free Cash Flow figures are available to summarize.

Free Cash Flow history

Currency unavailable · from the cash flow

No Free Cash Flow data reported for this period type.

Free Cash Flow vs competitors

How AVLN compares with its peers on the latest reported figures

AVLN Competitors
Free Cash Flow for AVLN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INSMInsmed IncorporatedLTM Jun 2026$837.67M USD-3.6%+33.1%73.6%
VCREVicore Pharma Holding ABLTM Jun 2026SEK 225.86M SEK-31.6%+7.4%16982.6%
MNKDMannKind CorporationLTM Mar 2026$12.72M USD-41.7%—3.5%
GYREGyre Therapeutics, Inc.LTM Mar 2026$3.04M USD+128.8%—2.6%
AVLNAvalyn Pharma Inc. Common Stock—— ———
Peer median (excluding AVLN) —-17.6%+20.3%38.6%

Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Intrinsic Alpha fair value

Locked

Current Price

$27.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.